NCT04678648 2026-03-18
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Phase 1 Recruiting
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Engeneic Pty Limited
University of California, San Francisco